Efficacy and Safety of Dapagliflozin by Baseline Insulin Regimen ...

The benefits and safety of dapagliflozin were maintained in high-risk patients receiving high-dose or intensive insulin regimens including SA insulin.

Cardiovascular (CV), renal, metabolic, and safety outcomes with dapagliflozin versus placebo by insulin dose and regimen were studied with Cox regression ...

Efficacy and Safety of Dapagliflozin by Baseline Insulin Regimen ...

Dapagliflozin reduced cardiovascular death/hospitalization for heart failure among overall insulin users (HR [95% CI] 0.82[0.69-0.97]), and ...

Efficacy and Safety of Dapagliflozin by Baseline Glycemic Status

Dapagliflozin safely reduced kidney and cardiovascular events independent of baseline glycemic status. Introduction. In the Dapagliflozin and Prevention of ...

Efficacy and Safety of Dapagliflozin by Baseline Insulin Regimen ...

The HR for major adverse CV events with dapagliflozin among insulin users (0.84 [0.74-0.97]) was similar irrespective of regimen or dose (Pinteraction = 0.75 ...

Efficacy and Safety of Dapagliflozin According to Background Use of ...

Importance Dapagliflozin was shown to reduce the cardiovascular (CV) and kidney outcomes in patients with type 2 diabetes. However, data are ...

Efficacy and Safety of Dapagliflozin by Baseline Insulin Regimen ...

Decreases in HbA1c, weight, and systolic blood pressure with dapagliflozin were seen regardless of insulin dose or regimen. The known safety ...

Efficacy and safety of dapagliflozin in addition to insulin therapy in ...

Patients in the dapagliflozin group showed an adjusted decrease in HbA1c of −0.55% from baseline, whereas the placebo showed a marginal increase ...

Efficacy and Safety of Dapagliflozin by Baseline Insulin Regimen ...

Efficacy and Safety of Dapagliflozin by Baseline Insulin Regimen and Dose: Post Hoc Analyses From DECLARE-TIMI 58. Authors. Pollack, Rena; Raz, Itamar ...

Efficacy and safety of dapagliflozin, a sodium glucose cotransporter ...

Clinical trials published to date show that dapagliflozin is safe and effective as monotherapy or as an add-on to insulin or oral antidiabetic ...

Long-Term Efficacy of Dapagliflozin in Patients With Type 2 ...

In this 24-week randomized trial, adding dapagliflozin to insulin therapy for type 2 diabetics with inadequate glycemic control resulted in ...

Efficacy and safety of dapagliflozin, added to therapy of patients with ...

This study is being carried out to see if Dapagliflozin in addition to insulin is effective and safe in treating patients with type 2 diabetes when compared ...

Efficacy and safety of dapagliflozin in patients with inadequately ...

Our results suggest that dapagliflozin is a promising adjunct treatment to insulin to improve glycaemic control in patients with inadequately ...

Efficacy and safety of dapagliflozin in patients with inadequately ...

Our results suggest that dapagliflozin is a promising adjunct treatment to insulin to improve glycaemic control in patients with inadequately controlled type 1 ...

Efficacy and safety of dapagliflozin as monotherapy in... - Medicine

Six trials with total of 2033 patients provided data of HbA1c changed from baseline. The result shown that dapagliflozin produced greater mean reductions in ...

Long‐term efficacy and safety of dapagliflozin in patients with ... - DOI

From baseline to 52 weeks, dapagliflozin 5 and 10 mg were associated with reduction in HbA1c (difference [95% CI] vs. placebo: −0.20% [−0.34, − ...

week) efficacy and safety of dapagliflozin as an adjunct to insulin ...

9,10 Although insulin therapy represents life-saving treatment for patients with T1D, most patients experience treatment-related hypoglycaemia ...

Clinical Effectiveness and Impact on Insulin Therapy Cost After ...

Reduction in HbA1c and body weight along with minimal side effects was observed. Addition of dapagliflozin reduced the insulin daily dose ...

Long‐term efficacy and safety of dapagliflozin in patients with ... - DOI

Baseline characteristics were similar between treatment groups. At week 24, reductions were seen with dapagliflozin 5 and 10 mg compared with ...

Efficacy and safety of dapagliflozin in patients with type 2 diabetes ...

Efficacy and safety of dapagliflozin in patients with type 2 diabetes on insulin ± metformin regimens · ePoster # 744 · Session: PS 063 SGLT-2 inhibitors: long- ...